Blair William & Co. IL increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 468,880 shares of the medical equipment provider's stock after buying an additional 4,101 shares during the period. Intuitive Surgical comprises about 0.7% of Blair William & Co. IL's holdings, making the stock its 29th biggest position. Blair William & Co. IL owned about 0.13% of Intuitive Surgical worth $244,737,000 as of its most recent filing with the SEC.
Other hedge funds have also added to or reduced their stakes in the company. Atala Financial Inc bought a new stake in Intuitive Surgical in the 4th quarter valued at about $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $31,000. Finally, Decker Retirement Planning Inc. bought a new position in Intuitive Surgical in the 4th quarter worth approximately $36,000. Institutional investors own 83.64% of the company's stock.
Insider Activity
In related news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by insiders.
Analysts Set New Price Targets
A number of brokerages have issued reports on ISRG. Piper Sandler restated an "overweight" rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Truist Financial dropped their price objective on Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating on the stock in a report on Monday, March 17th. Jefferies Financial Group lifted their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Robert W. Baird lowered their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a report on Tuesday, March 18th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and boosted their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $611.86.
Check Out Our Latest Analysis on ISRG
Intuitive Surgical Stock Performance
NASDAQ:ISRG traded down $0.09 during mid-day trading on Monday, reaching $491.75. The stock had a trading volume of 806,866 shares, compared to its average volume of 1,524,313. The stock has a market capitalization of $175.15 billion, a P/E ratio of 76.87, a P/E/G ratio of 5.85 and a beta of 1.43. The firm has a 50 day moving average price of $556.28 and a two-hundred day moving average price of $532.97. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.